SAN DIEGO, June 02, 2025 -- BioAtla, Inc. (Nasdaq: BCAB) (the “Company”), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the...
Bloodhound Technologies created a SaaS (Software as a Service) delivery platform aimed at helping healthcare payers control fraud and waste through a real-time claims processing environment.
Sold in 2011 to Verisk Analytics, Bloodhound customers included commercial health plans, state Medicaid agencies, and third-party administrators (TPAs) focused on combatting healthcare fraud through an emphasis on real-time adjudication, transparency for all participants in the claims cycle, business intelligence, and increased auto-adjudication and processing efficiencies.
Website
© 2025 Pappas Capital, LLC. ALL RIGHTS RESERVED.